Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWh Smith Regulatory News (SMWH)

Share Price Information for Wh Smith (SMWH)

Share Price is delayed by 15 minutes
Get Live Data
506.00    -2.00 (-0.39%)
Bid:
503.50
Ask:
505.00
Spread: 1.50 (0.298%)
Market Cap: £630.96m
SMWH Live PriceLast checked at - London Stock Exchange

Intraday Wh Smith Share Chart

Trading Statement

21 May 2019 07:00

RNS Number : 6217Z
WH Smith PLC
21 May 2019
 

WH Smith PLC

 

21 May 2019

 

Trading Update for the 11 Week Period to 18 May 2019

 

Strong sales across the Group

 

In the 11 week period from 1 March to 18 May 2019 total Group sales were up 15% (up 4% excluding InMotion) with like-for-like sales up 1% compared to last year.

 

WH Smith Travel

 

In our Travel business total sales were up 26% (up 7% excluding InMotion) and like-for-like sales were up 3%. This good performance reflects our ongoing focus on format development, customer service, space and category management as well as our continued investment in our UK and international businesses. Gross margin is in line with plan and our new store opening programme is on track both in the UK and internationally. We are on target to open around 20 units in the UK including 10 hospital stores.

 

Our new large format Travel stores in the UK are performing well. Both landlord and customer reaction to our recently opened new WH Smith pharmacy format in Gatwick North terminal has been positive.

 

Our hospital channel continues to grow strongly. It will overtake rail to become our second biggest channel, by revenue, this financial year and we see good potential to grow our hospital channel further.

 

Our International business continues to grow strongly and our integration of InMotion is progressing well. Our acquisition of InMotion gives us a business with the potential to grow both in its domestic US market as well as overseas, and we recently opened our first InMotion store outside the US, in Alicante Spain.

 

WH Smith High Street

 

In our High Street business we continue with our profit focused strategy. Total sales were down 1% and like-for-like sales were also down 1%. Gross margin continues to improve, and cost savings have been delivered in line with plan.

 

Our stationery business continues to perform well and we continue to invest in developing our ranges and allocating additional space in stores.

 

We now have 184 Post Office franchises open including 17 new Post Offices. Customer reaction to the new modern environment and extended opening hours has been positive.

 

Stephen Clarke, Group Chief Executive commented: "We have delivered a strong sales performance in the third quarter in both our Travel and High Street businesses. Whilst there is some uncertainty in the broader economic and political environment, we are well placed as we approach the key summer trading period in Travel. We continue to focus on profitable growth, cash generation and investing in the business to position us well for the future. We remain confident in the outcome for the full year."

 

Enquiries:

 

WH Smith PLC

Mark Boyle Investor Relations 020 3981 1285

Nicola Hillman Media Relations 01793 563354

 

Brunswick

Fiona Micallef-Eynaud / Cerith Evans 0207 404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAPSEAEFNEFF
Date   Source Headline
25th Mar 20259:11 amRNSHolding(s) in Company
25th Mar 20257:00 amRNSSuccessful completion of refinancing
18th Mar 20255:37 pmRNSTransaction in Own Shares
17th Mar 20255:12 pmRNSTransaction in Own Shares
14th Mar 20255:23 pmRNSTransaction in Own Shares
13th Mar 20255:12 pmRNSTransaction in Own Shares
12th Mar 20256:10 pmRNSTransaction in Own Shares
11th Mar 20256:01 pmRNSTransaction in Own Shares
10th Mar 20256:16 pmRNSTransaction in Own Shares
7th Mar 20255:35 pmRNSTransaction in Own Shares
6th Mar 20255:19 pmRNSTransaction in Own Shares
6th Mar 20253:51 pmRNSHolding(s) in Company
5th Mar 20255:28 pmRNSTransaction in Own Shares
4th Mar 20255:38 pmRNSTransaction in Own Shares
3rd Mar 20255:33 pmRNSTransaction in Own Shares
3rd Mar 20259:43 amRNSTotal Voting Rights
28th Feb 20255:30 pmRNSTransaction in Own Shares
27th Feb 20255:37 pmRNSTransaction in Own Shares
26th Feb 20255:34 pmRNSTransaction in Own Shares
25th Feb 20255:36 pmRNSTransaction in Own Shares
25th Feb 20258:46 amRNSBlock listing Interim Review
24th Feb 20255:52 pmRNSTransaction in Own Shares
21st Feb 20255:19 pmRNSTransaction in Own Shares
20th Feb 20255:44 pmRNSTransaction in Own Shares
19th Feb 20255:53 pmRNSTransaction in Own Shares
18th Feb 20255:14 pmRNSTransaction in Own Shares
17th Feb 20255:54 pmRNSTransaction in Own Shares
14th Feb 20255:50 pmRNSTransaction in Own Shares
13th Feb 20255:58 pmRNSTransaction in Own Shares
12th Feb 20255:50 pmRNSTransaction in Own Shares
11th Feb 20255:57 pmRNSTransaction in Own Shares
10th Feb 20255:41 pmRNSTransaction in Own Shares
7th Feb 20255:36 pmRNSTransaction in Own Shares
6th Feb 20255:43 pmRNSTransaction in Own Shares
5th Feb 20255:55 pmRNSTransaction in Own Shares
4th Feb 20255:36 pmRNSTransaction in Own Shares
3rd Feb 20255:51 pmRNSTransaction in Own Shares
31st Jan 202512:00 pmRNSTotal Voting Rights
30th Jan 20259:43 amRNSResult of AGM
29th Jan 20254:19 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNSTrading Statement
28th Jan 20255:51 pmRNSTransaction in Own Shares
27th Jan 20255:59 pmRNSTransaction in Own Shares
27th Jan 20257:00 amRNSResponse to press speculation
24th Jan 20255:56 pmRNSTransaction in Own Shares
23rd Jan 20255:43 pmRNSTransaction in Own Shares
23rd Jan 20259:31 amRNSHolding(s) in Company
22nd Jan 20255:57 pmRNSTransaction in Own Shares
21st Jan 20255:15 pmRNSTransaction in Own Shares
20th Jan 20255:50 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.